Evidence map›Paper›PMID 38628726›Full record

ArticleHeliyon2024

Baicalin reduces inflammation to inhibit lung cancer via targeting SOCS1/NF-κB/STAT3 axis.

Lijuan Guo, Ming Yue, Chengyuan Ma, Yunjing Wang, Jiejie Hou, Hong Li

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Bioactive Flavonoids fromDrug design, development and therapy · 2026
    Review
  8. Dual action of herbal compounds inFrontiers in immunology · 2026
    Review
  9. Review
  10. Review
  11. Baicalin alleviates HScientific reports · 2025
    Article
  12. Review
  13. Baicalin RelievesBiomolecules · 2025
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lijuan GuoSchool of Pharmacy, Henan University, Kaifeng, 475004, China.
Ming YueSchool of Pharmacy, Henan University, Kaifeng, 475004, China.
Chengyuan MaSchool of Pharmacy, Henan University, Kaifeng, 475004, China.
Yunjing WangSchool of Pharmacy, Henan University, Kaifeng, 475004, China.
Jiejie HouSchool of Pharmacy, Henan University, Kaifeng, 475004, China.
Hong LiSchool of Pharmacy, Henan University, Kaifeng, 475004, China.
Henan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation affects several aspects of lung cancer progression including cell proliferation, metastasis, apoptosis, angiogenesis, and drug resistance. Baicalin, an active component of

Indexed as

BaicalinInflammationLung cancerSOCS1/NF-κB/STAT3 axis

Identifiers

PMID38628726
PMCPMC11019232
OpenAlexW4394602110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.